Ojule J. D., Oranu E. O. and Enyindah C. E
Implanon, a single rod long acting reversible impla nt contraceptive containing 68 mg of etonogestrel i s relatively new, and has not been comprehensively ev aluated since its introduction at the University of Port Harcourt Teaching Hospital, Port Harcourt, Sou thern Nigeria. The study aimed at determining the acceptance, efficacy and safety profile of implanon in our centre. This is a cross-sectional retrospec tive study on whole clients who accepted implanon in UPT H between 1 st march 2006 and February 28, 2011. Data on the clients’ socio-demographic characterist ics, insertion and post insertion complications wer e extracted from their case files, entered into Micro soft Excel sheet, analyzed using Epi-Info statistica l software. Of the 4,065 acceptors of contraception, 168 had implanon, representing 4.1% of the acceptors. The age range was 20-44 years with a me an age of 32.3 ± 4.2 years. One hundred and sixty- two (96.4%) acceptors were married and multiparous. Up to 64.4% (87) clients who were on previous contraceptive method, changed over to implanon. The discontinuation rate was 5.4%, while failure rate was 0%. Implanon is therefore, highly effective, sa fe and an acceptable method of contraception in Por t Harcourt, Southern Nigeria.
Share this article